Thursday 31st March 2022 |
Text too small? |
Cannasouth Limited (NZX: CBD , Cannasouth), today released its Annual Report for the year ended 31 December 2021.
Changes versus 2021 Unaudited Preliminary Results
On 1 March 2022 Cannasouth released to the market its preliminary results for the year ended 31 December 2021 (Preliminary Results). The table in the attached '2021 Annual Report Announcement' document summarises the key results.
The Preliminary Results were prepared on the basis that the accounting treatment for the acquisition of Midwest Pharmaceutics NZ Ltd and Cannasouth Cultivation Ltd was subject to audit. The reclassification of pre-acquisition transactions has no cash flow impacts.
Included with this announcement are the following documents:
• 2021 Annual Report
• Revised Results Announcement Form
-ENDS-
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b